Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amifostine in Inoperable Stage II-III NSCLC Receiving Chemoradiotherapy
NCT00003313Phase 3Completed
- Sponsor
- NRG Oncology
- Start
- Sep 1998
- Primary completion
- Jul 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of amifostine in non-small cell lung cancer (NSCLC), sponsored by NRG Oncology. Started Sep 1998; status: completed.
02
Drugs
amifostine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00003313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003313.